Clinical trial · Observational
Remote Monitoring in Cancer Care: A Platform Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study investigates a device that closely monitors vital signs, as well as a smartphone application (app) that allows patients to respond to different questions and tests that will monitor for new symptoms. This study may help researchers understand if wearing the device is a better tool than standard vital sign assessment tools done only while at the doctor's office or hospital, and if using the smartphone app is a better tool than standard assessment tools used while in the doctor's office or hospital.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Carcinoma | Head and Neck Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Hematopoietic and Lymphoid Cell Neoplasm | Hematopoietic and Lymphoid Cell Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Lung Carcinoma | Lung Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Malignant Digestive System Neoplasm | Malignant Digestive System Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Malignant Solid Neoplasm | Malignant Solid Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Computer-Assisted Intervention | Other | — | UNRESOLVED |
| Patient Monitoring | Procedure | — | UNRESOLVED |
| Questionnaire Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Arm 1 (wearable device[s], smartphone app)
- description
- Patients undergoing CAR-T therapy use the Biofourmis wearable device(s) and smartphone app to answer a series of questions about health and neurologic symptoms a few times a day for 5 weeks.
- interventionNames
- Other: Computer-Assisted Intervention
- Procedure: Patient Monitoring
- label
- Arm 2 (wearable device[s], smartphone app, questionnaires)
- description
- Patients undergoing radiation therapy (RT) for head and neck, lung, or gastrointestinal cancers use the Biofourmis wearable device(s) for 90 days after completion of RT. Patients also use the smartphone app to answer a series of questions about health and neurologic symptoms before start of RT, after completion of RT, 3 months after completion of RT, and 1 year after completion of RT. In addition, patients complete weekly questionnaires regarding side effects and tolerance of the device.
- interventionNames
- Other: Computer-Assisted Intervention
- Procedure: Patient Monitoring
- Other: Questionnaire Administration
Primary outcomes (6)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * ARM 1: Age \>= 18 years * ARM 1: Provide written informed consent * ARM 1: Patients undergoing commercial CAR-T cell therapy in an outpatient setting * ARM 2: Age \>= 18 years * ARM 2: Provide written informed consent * ARM 2: Patients with a plan to undergo radiation therapy for lung, gastrointestinal, or head and neck cancer Exclusion Criteria: * ARM 1: Non-English speaking * ARM 1: Planned initiation of lymphodepleting chemotherapy in the inpatient setting * ARM 2: Non-English speaking
References
Publications (0)
Data not yet available